Skip to main content
. 2019 Apr 11;6(1):e000974. doi: 10.1136/openhrt-2018-000974

Table 1.

Patientcharacteristics in individuals with atrial fibrillation, by income

Characteristic All participants <$20 000 $20 000–$49 000 $50 000–$99 999 >$100 000 P value (standard) P value (trend)
n=295 n=35 n=99 n=97 n=64
Age 71.3±9.9 69.9±11.4 73.2±10.2 71.6±9.2 68.8±9.4 0.04 0.06
Sex (Male) 177 (60.0%) 16 (45.7%) 55 (55.6%) 66 (68.0%) 40 (62.5%) 0.09 0.04
White race 281 (95.3%) 34 (97.1%) 92 (92.9%) 95 (97.9%) 60 (93.8%) 0.01 0.64
BMI 31.4±7.41 33.2±9.09 31.4±7.50 31.4±7.77 30.5±5.39 0.41 0.13
CHF 54 (18.3%) 9 (25.7%) 23 (23.2%) 17 (17.5%) 5 (7.8%) 0.05 <0.01
HTN 210 (71.2%) 29 (82.9%) 69 (69.7%) 71 (73.2%) 41 (64.1%) 0.24 0.16
DM 65 (22.0%) 7 (20.0%) 22 (22.2%) 22 (22.7%) 14 (21.9%) 0.99 0.84
Stroke/TIA 22 (7.5%) 2 (5.7%) 11 (11.1%) 3 (3.1%) 6 (9.4%) 0.16 0.68
Vascular disease 56 (19.0%) 4 (11.4%) 26 (26.3%) 16 (16.5%) 10 (15.6%) 0.13 0.42
Education <0.01 <0.01
 ≤HS or vocational 100 (33.9%) 21 (60.0%) 47 (47.5%) 28 (28.9%) 4 (6.3%)
 Some college 62 (21.0%) 7 (20.0%) 24 (24.2%) 22 (22.7%) 9 (14.1%)
 Bachelor’s 70 (23.7%) 6 (17.1%) 18 (18.2%) 29 (29.9%) 17 (26.6%)
 Graduate 63 (21.4%) 1 (2.9%) 10 (10.1%) 18 (18.6%) 34 (53.1%)
S-TOHFLA Score 29.6±4.92 27.3±5.88 28.9±6.26 30.2±3.51 31.0±2.89 <0.01 <0.01
Treatment
 Pulmonary vein isolation 59 (20.0%) 6 (17.1%) 20 (20.2%) 15 (15.5%) 18 (28.1%) 0.25 0.28
 Electrical cardioversion 58 (19.7%) 6 (17.1%) 18 (18.2%) 19 (19.6%) 15 (23.4%) 0.83 0.38
 Cardioversion by medication 5 (1.7%) 0 (0.0%) 0 (0.0%) 3 (3.1%) 2 (3.1%) 0.23 0.07
Anti-arrhythmics (any) 72 (24.4%) 6 (17.1%) 21 (21.2%) 25 (25.8%) 20 (31.3%) 0.35 0.07

Standard p value using χ2 tests for categorical variables and ANOVA for continuous variables. P value trend test using the Jonckheere-Terpstra test for ordered differences among classes.

BMI, body mass index; CHF, congestive heart failure; DM, diabetes mellitus; HS, high school; HTN, hypertension; S-TOFHLA, short-test of functional health literacy in adults; TIA, transient ischaemic attack.